Page 83 - Read Online
P. 83

Page 6 of 7                                                   Sazonova et al. Vessel Plus 2019;3:8  I  http://dx.doi.org/10.20517/2574-1209.2019.01

                          Table 5. Spearman correlation analysis of 11 mitochondrial genome mutations with cardiac angina
                           Mutation                  Correlation coefficient     Significance
                           m.12315G>A                     0.079                    0.121
                           m.652delG                      0.061                    0.224
                           m.3336T>C                      0.047                    0.342
                           m.14459G>A                     0.116                    0.034**
                           m.5178C>A                      0.092                    0.068*
                           m.13513G>A                     -0.075                   0.129
                           m.652insG                      -0.078                   0.124
                           m.3256C>T                      0.069                    0.218
                           m.15059G>A                     -0.122                   0.036**
                           m.1555A>G                      -0.065                   0.217
                           m.14846G>A                     -0.068                   0.222

                                                      **P ≤ 0.05; *P ≤ 0.1

               MtDNA mutations m.14459G>A and m.5178C>A can be used for evaluation the predisposition of individuals
               to atherosclerotic lesions. At the same time, mitochondrial genome mutation m.15059G>A may be used for
               gene therapy of atherosclerosis.

               DECLARATIONS
               Authors’ contributions
               Conception, design and statistical analysis: Sazonova MA
               Pyrosequencing of PCR fragments: Sazonova MA, Sinyov VV
               PCR: Ryzhkova AI, Shkurat TP
               DNA extraction: Sazonova MD, Nikitina NN
               Administrative and material support: Sobenin IA, Orekhov AN

               Availability of data and materials
               The data were strictly obtained from medical records according to the privacy policy and ethics code of our
               institute.


               Financial support and sponsorship
               This work was supported by the Russian Foundation for Basic Research (19-015-00479).


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               The study was carried out in accordance with the Declaration of Helsinki. The study protocol was inspected
               and approved by the Ethics Committee of the Institute of General Pathology and Pathophysiology. Each
               study participant has signed a written informed consent to participate in this investigation.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2019.

               REFERENCES
               1.   Hoffmann U, Massaro JM, D’Agostino RB Sr, Kathiresan S, Fox CS, et al. Cardiovascular event prediction and risk reclassification by
                   coronary, aortic, and valvular calcification in the Framingham heart study. J Am Heart Assoc 2016;5:e003144.
   78   79   80   81   82   83   84   85   86   87   88